175 related articles for article (PubMed ID: 10728705)
41. Systematic Analysis of Cytostatic TGF-Beta Response in Mesenchymal-Like Hepatocellular Carcinoma Cell Lines.
Gungor MZ; Uysal M; Ozturk M; Senturk S
J Gastrointest Cancer; 2021 Dec; 52(4):1320-1335. PubMed ID: 34463913
[TBL] [Abstract][Full Text] [Related]
42. Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal.
Wang Q; Yu T; Yuan Y; Zhuang H; Wang Z; Liu X; Feng M
J Surg Oncol; 2013 Mar; 107(4):422-7. PubMed ID: 22833259
[TBL] [Abstract][Full Text] [Related]
43. Molecular signatures and prognosis of hepatocellular carcinoma.
Hoshida Y
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):311-22. PubMed ID: 21769080
[TBL] [Abstract][Full Text] [Related]
44. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells.
Huang S; He X; Ding J; Liang L; Zhao Y; Zhang Z; Yao X; Pan Z; Zhang P; Li J; Wan D; Gu J
Int J Cancer; 2008 Aug; 123(4):972-8. PubMed ID: 18508316
[TBL] [Abstract][Full Text] [Related]
45. Transforming growth factor beta 1 overexpression is closely related to invasiveness of hepatocellular carcinoma.
Lee D; Chung YH; Kim JA; Lee YS; Lee D; Jang MK; Kim KM; Lim YS; Lee HC; Lee YS
Oncology; 2012; 82(1):11-8. PubMed ID: 22269311
[TBL] [Abstract][Full Text] [Related]
46. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.
Liu J; Chen S; Wang W; Ning BF; Chen F; Shen W; Ding J; Chen W; Xie WF; Zhang X
Cancer Lett; 2016 Aug; 379(1):49-59. PubMed ID: 27216982
[TBL] [Abstract][Full Text] [Related]
47. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.
Yan X; Wu J; Jiang Q; Cheng H; Han JJ; Chen YG
J Mol Cell Biol; 2018 Feb; 10(1):48-59. PubMed ID: 29036306
[TBL] [Abstract][Full Text] [Related]
48. The Role of TGF-β/SMAD Signaling in Hepatocellular Carcinoma: from Mechanism to Therapy and Prognosis.
Xin X; Cheng X; Zeng F; Xu Q; Hou L
Int J Biol Sci; 2024; 20(4):1436-1451. PubMed ID: 38385079
[TBL] [Abstract][Full Text] [Related]
49. Activation of the transforming growth factor-β/SMAD transcriptional pathway underlies a novel tumor-promoting role of sulfatase 1 in hepatocellular carcinoma.
Dhanasekaran R; Nakamura I; Hu C; Chen G; Oseini AM; Seven ES; Miamen AG; Moser CD; Zhou W; van Kuppevelt TH; van Deursen JM; Mounajjed T; Fernandez-Zapico ME; Roberts LR
Hepatology; 2015 Apr; 61(4):1269-83. PubMed ID: 25503294
[TBL] [Abstract][Full Text] [Related]
50. Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF-β/SMAD signalling.
Zhang Z; Wu W; Jiao H; Chen Y; Ji X; Cao J; Yin F; Yin W
Br J Pharmacol; 2023 Jun; 180(12):1562-1581. PubMed ID: 36581319
[TBL] [Abstract][Full Text] [Related]
51. Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.
Dzieran J; Fabian J; Feng T; Coulouarn C; Ilkavets I; Kyselova A; Breuhahn K; Dooley S; Meindl-Beinker NM
PLoS One; 2013; 8(8):e72252. PubMed ID: 23991075
[TBL] [Abstract][Full Text] [Related]
52. Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.
Chen J; Zaidi S; Rao S; Chen JS; Phan L; Farci P; Su X; Shetty K; White J; Zamboni F; Wu X; Rashid A; Pattabiraman N; Mazumder R; Horvath A; Wu RC; Li S; Xiao C; Deng CX; Wheeler DA; Mishra B; Akbani R; Mishra L
Gastroenterology; 2018 Jan; 154(1):195-210. PubMed ID: 28918914
[TBL] [Abstract][Full Text] [Related]
53. Liver tumors and host defense.
Tabor E
Semin Liver Dis; 1997; 17(4):351-5. PubMed ID: 9408971
[TBL] [Abstract][Full Text] [Related]
54. Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis.
Wu MZ; Yuan YC; Huang BY; Chen JX; Li BK; Fang JH; Zhuang SM
Signal Transduct Target Ther; 2021 Nov; 6(1):395. PubMed ID: 34785655
[TBL] [Abstract][Full Text] [Related]
55. KLF2 inhibits TGF-β-mediated cancer cell motility in hepatocellular carcinoma.
Li Y; Tu S; Zeng Y; Zhang C; Deng T; Luo W; Lian L; Chen L; Xiong X; Yan X
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):485-494. PubMed ID: 32318691
[TBL] [Abstract][Full Text] [Related]
56. Darbepoetin inhibits proliferation of hepatic cancer cells in the presence of TGF-β.
Ehnert S; Freude T; Eicher C; Burkhardt B; Martínez Sánchez JJ; Neumann J; Mühl-Benninghaus R; Dooley S; Pscherer S; Nussler AK
Arch Toxicol; 2014 Jan; 88(1):89-96. PubMed ID: 23877120
[TBL] [Abstract][Full Text] [Related]
57. Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer.
Coulouarn C; Factor VM; Thorgeirsson SS
Hepatology; 2008 Jun; 47(6):2059-67. PubMed ID: 18506891
[TBL] [Abstract][Full Text] [Related]
58. Resolving the Combinatorial Complexity of Smad Protein Complex Formation and Its Link to Gene Expression.
Lucarelli P; Schilling M; Kreutz C; Vlasov A; Boehm ME; Iwamoto N; Steiert B; Lattermann S; Wäsch M; Stepath M; Matter MS; Heikenwälder M; Hoffmann K; Deharde D; Damm G; Seehofer D; Muciek M; Gretz N; Lehmann WD; Timmer J; Klingmüller U
Cell Syst; 2018 Jan; 6(1):75-89.e11. PubMed ID: 29248373
[TBL] [Abstract][Full Text] [Related]
59. Expression of transforming growth factor-beta 1 mRNA in human hepatocellular carcinoma.
Ito N; Kawata S; Tamura S; Takaishi K; Yabuuchi I; Matsuda Y; Nishioka M; Tarui S
Jpn J Cancer Res; 1990 Dec; 81(12):1202-5. PubMed ID: 1703520
[TBL] [Abstract][Full Text] [Related]
60. Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma.
Chen J; Gingold JA; Su X
Trends Mol Med; 2019 Nov; 25(11):1010-1023. PubMed ID: 31353124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
